Safety analysis of the BCL-2 inhibitor venetoclax for CLL
How durable are the responses of CLL patients to therapy?
Antifungal prophylaxis in leukemia patients
Vaccination after stem cell transplant – why and when?
What leads to shorter progression-free survival in CLL patients?